Abeona Therapeutics Newsroom

Abeona Therapeutics Analyst Ratings

BenzingaNov 25 20:46

H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 25 20:31

Positive Outlook for Abeona Therapeutics: FDA Acceptance and Strategic Initiatives Reinforce Buy Rating

TipRanksNov 25 20:00

H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $15

Futu NewsOct 31 18:31

Abeona Therapeutics Analyst Ratings

BenzingaOct 29 23:49

Abeona Therapeutics Price Target Maintained With a $18.00/Share by Cantor Fitzgerald

Dow JonesSep 20 23:19

Stifel Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $21

Futu NewsAug 15 20:31

Analysts Conflicted on These Healthcare Names: Abeona Therapeutics (ABEO), Cyclacel Pharmaceuticals (CYCC) and Cardinal Health (CAH)

TipRanksAug 15 20:24

Abeona Therapeutics Analyst Ratings

BenzingaAug 14 19:33

HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $15 Price Target

BenzingaAug 14 19:33

H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $15

Futu NewsAug 14 19:31

Buy Rating on Abeona Therapeutics Bolstered by Positive Medicare Decisions and FDA Approval Progress

TipRanksAug 14 18:43

Stifel Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $21

Futu NewsAug 13 18:34

Abeona Therapeutics Analyst Ratings

BenzingaJul 12 18:12

Stifel Nicolaus Sticks to Its Buy Rating for Abeona Therapeutics (ABEO)

TipRanksJul 9 19:37

Abeona Therapeutics Analyst Ratings

BenzingaJul 3 18:18

Abeona Therapeutics Analyst Ratings

BenzingaMay 30 20:05

Abeona Therapeutics Inc.: Stifel starts insurance with a purchase rating; target price is $21

Zhitong FinanceMay 30 18:44

Abeona Therapeutics Analyst Ratings

BenzingaMay 16 23:15

Cantor Fitzgerald Maintains Overweight on Abeona Therapeutics, Lowers Price Target to $21

BenzingaMay 16 23:15